Drug use issues and actions. Physician order entry reduces inappropriate vancomycin prescribing, VRE rates.
- Published in:
- 2001
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2001 AND VI 36 AND IP 7
Results: 25
1
2
Drug use issues and actions. Collaborative drug therapy agreements lead to improved diabetes management.
- Published in:
- 2001
- Publication type:
- Journal Article
3
Researcher outlines cost-effectiveness framework for pharmacogenomics-based therapies.
- Published in:
- 2001
- Publication type:
- Journal Article
4
Update on dyslipidemia management: overview of the NCEP Adult Treatment Panel III guidelines.
- Published in:
- 2001
- By:
- Publication type:
- Journal Article
5
Atypical antipsychotics for schizophrenia: their collective role and comparative profiles.
- Published in:
- 2001
- By:
- Publication type:
- Journal Article
6
Olmesartan medoxomil (CS-866): an angiotensin II receptor blocker for treatment of hypertension.
- Published in:
- 2001
- By:
- Publication type:
- Journal Article
7
Health care policies in the spotlight after Senate majority switch.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 545
- By:
- Publication type:
- Article
8
Drug use issues and actions IN BRIEF.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 542
- Publication type:
- Article
9
Physician order entry reduces in appropriate vancomycin prescribing, VRE rates.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 538
- Publication type:
- Article
10
Collaborative drug therapy agreements lead to improved diabetes management.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 538
- Publication type:
- Article
11
As AMCP Format finds a foothold, lessons and dissemination plans emerge.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 536
- Publication type:
- Article
12
Electronic prescribing consultant sorts out hype from reality, profiles major vendors.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 532
- Publication type:
- Article
13
Researcher outlines cost-effectiveness framework for pharmacogenomics-based therapies.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 522
- Publication type:
- Article
14
Three-tier benefit trims payer costs without short-term effects on utilization, clinical outcomes.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 522
- Publication type:
- Article
15
Update on dyslipidemia management: Overview of the NCEP Adult Treatment Panal III guidelines.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 518
- By:
- Publication type:
- Article
16
Atypical antipsychotics for schizophrenia: Their collective role and comparative profiles.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 500
- By:
- Publication type:
- Article
17
Olmesartan medoxomil (CS-866): An angiotensin II receptor blocker for treatment of hypertension.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 487
- By:
- Publication type:
- Article
18
Agonizing over eczema.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 485
- Publication type:
- Article
19
Derm drugs 101: Specialist surveys strategies in overlooked formulary niche.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 485
- Publication type:
- Article
20
Low-cut intranasal antibiotic reduces sternal wound infections in open-heart surgery patients.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 483
- Publication type:
- Article
21
ARBs show renoprotective effects in type 2 diabetes independent of blood pressure lowering.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 483
- Publication type:
- Article
22
FDA actions IN BRIEF.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 482
- Publication type:
- Article
23
PIPELINE PREVIEW.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 481
- Publication type:
- Article
24
New Combinations: Yasmin.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 481
- Publication type:
- Article
25
New Indications: Xeloda.
- Published in:
- Formulary, 2001, v. 36, n. 7, p. 481
- Publication type:
- Article